[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Dermatology Times [@DermTimesNow](/creator/twitter/DermTimesNow) on x 31.8K followers Created: 2025-07-20 19:24:08 UTC 📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis, with a dose-dependent response and manageable safety profile. #DermTwitter #AD #AtopicDerm XXX engagements  **Related Topics** [dermatology](/topic/dermatology) [Post Link](https://x.com/DermTimesNow/status/1947014682063053309)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Dermatology Times @DermTimesNow on x 31.8K followers
Created: 2025-07-20 19:24:08 UTC
📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis, with a dose-dependent response and manageable safety profile.
#DermTwitter #AD #AtopicDerm
XXX engagements
Related Topics dermatology
/post/tweet::1947014682063053309